Skip to main content

Advertisement

SpringerLink
Log in

The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Ascorbic acid is an essential micronutrient and is considered to have an antioxidant function in living systems. For the past several decades, ascorbic acid has been the subject of considerable interest as an anticancer agent. Several studies have shown that ascorbic acid is cytotoxic to a variety of cancer cells, whereas normal cells are relatively resistant to such cytotoxic action. In this study, we propose a putative molecular mechanism that accounts for the preferential cytotoxicity of ascorbic acid against cancer cells.

Methods

Standard and lysed version of alkaline single-cell gel electrophoresis (Comet assay); ferrous oxidation–xylenol orange (FOX) assay.

Results

We show that ascorbic acid acts as a prooxidant and leads to oxidative DNA breakage in lymphocytes and lymphocyte nuclei. Scavengers of reactive oxygen species were able to inhibit ascorbic acid-induced DNA breakage, suggesting the involvement of reactive oxygen species in this reaction. We further show that such DNA breakage is inhibited by both iron and copper chelators in cells, whereas in nuclei, similar inhibition was achieved only by copper chelators, indicating an important role of chromatin-bound copper in the prooxidant cellular DNA breakage by ascorbic acid.

Conclusion

We propose that the copper-dependent cellular redox status is an important element in the cytotoxic action of ascorbic acid against cancer cells. It is well established that cellular copper levels are considerably elevated in various malignancies. Therefore, cancer cells may be more subject to electron transfer between copper and ascorbate to generate reactive oxygen species. In light of these observations and those in literature, in this paper we explain that the preferential cytotoxicity of ascorbic acid against cancer cells is the result of elevated copper levels in such cells. Further, this study identifies nuclear copper as a novel molecular target for cytotoxic action of ascorbic acid, which has implications for its chemotherapeutic properties against cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. De Laurenzi V, Melino G, Savini I, Annicchiarico-Petruzelli M, Finnazi-agro A, Avigliano L (1995) Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. Eur J Cancer 31:463–466

    Article  Google Scholar 

  2. Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA (1995) Intravenous ascorbate as tumor cytotoxic and tumor therapeutic agent. Med Hypothesis 44:207–213

    Article  CAS  Google Scholar 

  3. Park CH, Kim WS, Park C, Lee MH, Boo YC, Yoon SS et al (1999) Clinical disease suppression and reduction in acute myeloid leukemia and solid tumors by very high dose of L-ascorbic acid: a new concept and in search of molecular targets. Clin Cancer Res 5(Suppl 1):3784s

    Google Scholar 

  4. Kim WS, Lee MH, Chung CW, Kim K, Han SS, Park Q et al (2001) Clinical response in AML with manipulation of L-ascorbic acid (LAA) level in vivo to its extremes. Exp Hematol 29(Suppl 1):25

    Google Scholar 

  5. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR et al (2005) Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 102:13604–13609

    Article  CAS  PubMed  Google Scholar 

  6. Cameron E, Campbell A (1974) The ortho molecular treatment of cancer II. Clinical trial of high-dose ascorbic supplements in advanced human cancers. Chem Biol Interact 9:285–315

    Article  CAS  PubMed  Google Scholar 

  7. Cameron E, Pauling L (1978) Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancers. Proc Natl Acad Sci USA 75:4538–4542

    Article  CAS  PubMed  Google Scholar 

  8. Creagen ET, Moertal CG, O’Fallon JR, Schutt AJ, O’Connell MJ, Rubin AJ et al (1979) Failure of high-dose Vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. New England J Med 301:687–690

    Article  Google Scholar 

  9. Moertal CG, Fleming TR, Creagen ET, Rubin AJ, O’Connell MJ, Ames MM (1985) High-dose Vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double blind comparison. New England J Med 312:137–141

    Article  Google Scholar 

  10. Omaya TS, Scala JH, Jacob RA (1986) Plasma ascorbic acid in adult males: effects of depletions and supplementation. J Am Coll Nutr 44:257–264

    Google Scholar 

  11. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewit S, Katz A et al (2004) Vitamin C pharmacokinetics: implications for oral and intravenous use. Annuls Intern Med 140:533–538

    CAS  Google Scholar 

  12. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M (2008) Pharmacologic doses of ascorbate act as a prooxidant and decrease growth aggressive tumor xenografts in mice. Proc Natl Acad Sci USA 105:11105–11109

    Article  CAS  PubMed  Google Scholar 

  13. Halliwell B (2003) Oxidative stress in cell culture: an under appreciated problem? FEBS lett 540:3–6

    Article  CAS  PubMed  Google Scholar 

  14. Clement MV, Long LH, Ramalingam J, Halliwell B (2002) The cytotoxicity of dopamine may be an artifact of cell culture. J Neurochem 81:414–421

    Article  CAS  PubMed  Google Scholar 

  15. Shamim U, Hanif S, Ullah MF, Azmi AS et al (2008) Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanism. Free Radic Res 42:764–772

    Article  CAS  PubMed  Google Scholar 

  16. Bhat SH, Azmi AS, Hanif S, Hadi SM (2006) Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. IJBCB 38:2074–2081

    CAS  Google Scholar 

  17. Smets KA (1994) Programmed cell death (apoptosis) and the response to anticancer drugs. Anticancer Drugs 5:3–9

    Article  CAS  PubMed  Google Scholar 

  18. Burkitt MJ, Milne L, Nicotera P, Orrenius S (1996) 1, 10-Phenanthroline stimulates internucleosomal DNA fragmentation in isolated rat liver nuclei by promoting redox activity of endogenous copper ions. Biochem J 313:163–169

    CAS  PubMed  Google Scholar 

  19. Linder MC (1991) Nutritional biochemistry and metabolism. Elsevier, New York

    Google Scholar 

  20. Ebadi E, Swanson S (1998) The status of copper, zinc and metallothioneins in cancer patients. Prog Clin Biol Res 259:167–175

    Google Scholar 

  21. Yoshida D, Ikada Y, Nakayama S (1993) Quantitative analysis of copper, zinc and copper/zinc ratios in selective human brain tumors. J Neuro-Oncol 16:109–115

    Article  CAS  Google Scholar 

  22. Carpentieri U, Myers J, Thorpe L, Daeschner CW, Haggard ME (1986) Copper, zinc and iron in normal and leukemic lymphocytes in children. Cancer Res 46:981–984

    CAS  PubMed  Google Scholar 

  23. Pool-Zobel BL, Guigas C, Klein R, Neudecker CH, Renner HW, Schmezer P (1993) Assessment of genotoxic effects of lindane. Food Chem Toxicol 31:184–191

    Google Scholar 

  24. Szeto YT, Collins AR, Benzie IFF (2002) Effects of dietary antioxidants on DNA damage in lysed cells using a modified comet assay procedure. Mutat Res 500:31–38

    CAS  PubMed  Google Scholar 

  25. Kasamatsu T, Kohda K, Kawazoe Y (1996) Comparison of chemically induced DNA breakage in cellular and subcellular systems using the comet assay. Mutat Res 369:1–6

    Article  CAS  PubMed  Google Scholar 

  26. Long LH, Clement MV, Halliwell B (2000) Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (−)-epigallocatechin, (−)-epigallocatechingallate, (+)-catechin and quercitin to commonly used cell culture media. Biochem Biophys Res Commun 273:50–53

    Article  CAS  PubMed  Google Scholar 

  27. Bhat R, Hadi SM (1994) DNA breakage by tannic acid–Cu(II): sequence specificity of the reaction and involvement of Cu(II). Mutat Res 313:39–48

    CAS  PubMed  Google Scholar 

  28. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H et al (2000) Single cell gel electrophoresis/Comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221

    Article  CAS  PubMed  Google Scholar 

  29. Czene S, Tiback M, Harms-Ringdahl M (1997) pH-dependent DNA cleavage in permeabilized human fibroblasts. Biochem J 323:337–341

    CAS  PubMed  Google Scholar 

  30. Meneghini R, Martins EAL, Calderaro M (1993) Oxidative DNA damage and homeostasis of intracellular iron and copper ions. QUIMICA NOVA 16:377–380

    CAS  Google Scholar 

  31. Toth I, Rogers JT, McPhee JA, Elliot SM, Abramson SL, Bridges KR (1995) Ascorbic acid enhances iron-induced ferritin translation in human leukemia and hepatoma cells. J Biol Chem 270:2846–2852

    Article  CAS  PubMed  Google Scholar 

  32. Scarpa M, Stevanato R, Vigilino P, Rigo A (1983) Superoxide ion as active intermediate in the autooxidation of ascorbate by molecular oxygen: effect of superoxide dismutase. J Biol Chem 258:6695–6697

    CAS  PubMed  Google Scholar 

  33. Gupte A, Mumper RG (2008) Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 35:32–46

    Article  PubMed  Google Scholar 

  34. Singh NP (1997) Sodium ascorbate induces DNA single-strand breaks in human cells in vitro. Mutat Res 375:195–203

    CAS  PubMed  Google Scholar 

  35. Kuo KW, Chen SF, Wu CC, Chen DR, Lee JH (2002) Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res 89:1–11

    Article  CAS  PubMed  Google Scholar 

  36. Zuo XL, Chen JM, Zhou X, Li XL, Mei GY (2006) Levels of selenium, zinc, copper and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res 114:41–54

    Article  CAS  PubMed  Google Scholar 

  37. Wolfe JT, Ross D, Cohen GM (1994) A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett 352:59–62

    Article  Google Scholar 

  38. Held KD, Sylvester FC, Hopcia KL, Biaglow JE (1996) Role of Fenton chemistry thiol-induced toxicity and apoptosis. Radiat Res 14:542–553

    Article  Google Scholar 

  39. Pryor WA (1988) Why is hydroxyl radical the only radical that commonly binds to DNA? Hypothesis: it has rare combination of high electrophilicity, thermochemical reactivity and a mode of production near DNA. Free Rad Biol Med 4:219–233

    Article  CAS  PubMed  Google Scholar 

  40. Sakagami H, Satoh K, Hakeda Y, Kumegawa M (2000) Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol 46:129–143

    CAS  PubMed  Google Scholar 

  41. Devi GS, Prasad MH, Saraswathi I, Rao DN, Reddy PP (2000) Free radicals, antioxidant enzymes and lipid peroxidation in different types of leukemia. Clin Chim Acta 293:53–62

    Article  CAS  PubMed  Google Scholar 

  42. Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10:175–176

    Article  CAS  PubMed  Google Scholar 

  43. Kong Q, Beel JA, Lillehei KO (2000) A threshold concept for cancer therapy. Med Hypothesis 55:29–35

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the financial assistance provided by the University Grants Commission, New Delhi, under the DRS-II program.

Conflict of interest statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Life Sciences, AMU, Aligarh, UP, 202002, India

    M. F. Ullah, H. Y. Khan, H. Zubair, U. Shamim & S. M. Hadi

Authors
  1. M. F. Ullah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Y. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Zubair
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Shamim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. M. Hadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. M. Hadi.

Additional information

H.Y. Khan and H. Zubair contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ullah, M.F., Khan, H.Y., Zubair, H. et al. The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother Pharmacol 67, 103–110 (2011). https://doi.org/10.1007/s00280-010-1290-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-010-1290-4

Keywords

Search

Navigation